Brunna Boaventura

Behavior change support in the new era of obesity care

Evidence of the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to improve cardiometabolic health has increased rapidly, as has patient and public demand. This has, and continues to, reshape clinical practice and public health priorities. The World Health O...